Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Mar;227(3):424–432. doi: 10.1097/00000658-199803000-00015

Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.

G Otto 1, U Heuschen 1, W J Hofmann 1, G Krumm 1, U Hinz 1, C Herfarth 1
PMCID: PMC1191281  PMID: 9527066

Abstract

OBJECTIVE: This study compares the results of liver transplantation (LTx) and liver resection (LR) for hepatocellular carcinoma (HCC) to test the widespread hypothesis that LTx is the preferable approach for small HCCs. SUMMARY BACKGROUND DATA: With respect to scarcity of donor organs and poor results, LTxs for large HCCs are obsolete. Small HCC transplantations have been reported to result in an excellent survival rate. However, the data of comparative studies are controversial. METHODS: Patients who were treated curatively by LTx (n = 50) or LR (n = 52) for HCC were included in this retrospective study. Survival and freedom from recurrence were analyzed. Patients were stratified according to prognostic factors (pT classification, tumor size, number of tumor nodules, vascular infiltration, and cirrhosis). RESULTS: Overall, after LTx and LR the 3-year survival rate and recurrence rate were not significantly different. In the Cox analysis, tumor size (p = 0.02) and vascular infiltration (p = 0.04) were independent variables after LTx, whereas after LR, none of the tested prognostic parameters was significant. With regards to recurrence, tumor size was the only independent factor, after both LTx and LR (p = 0.02, respectively). Directly comparing the two therapeutic approaches, a 3-year survival rate in pT 1/2, oligocentric (1-5 nodules), and oligocentric and small tumors proved to be superior after LTx. The recurrence rate after LTx was superior to LR in pT 1/2 and oligocentric tumors. Remarkably, for small (< or = 5 cm) tumors, LTx and LR resulted in a similar 3-year survival rate and freedom from recurrence. CONCLUSIONS: According to our analysis, the oncological advantage of LTx compared with LR is questionable. This applies especially for small tumors. Superior results of LTx in early stage HCC and particularly in oligocentric tumors may be attributed to incorrect preoperative diagnosis. Nevertheless, LTx is a reasonable treatment for patients with early stage tumors if a LR is impossible because of tumor localization or poor functional hepatic capacity.

Full text

PDF
424

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belghiti J., Panis Y., Farges O., Benhamou J. P., Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991 Aug;214(2):114–117. doi: 10.1097/00000658-199108000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bismuth H., Chiche L., Adam R., Castaing D., Diamond T., Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993 Aug;218(2):145–151. doi: 10.1097/00000658-199308000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bismuth H., Houssin D., Ornowski J., Meriggi F. Liver resections in cirrhotic patients: a Western experience. World J Surg. 1986 Apr;10(2):311–317. doi: 10.1007/BF01658152. [DOI] [PubMed] [Google Scholar]
  4. Bronowicki J. P., Boudjema K., Chone L., Nisand G., Bazin C., Pflumio F., Uhl G., Wenger J. J., Jaeck D., Boissel P. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol. 1996 Mar;24(3):293–300. doi: 10.1016/s0168-8278(96)80007-9. [DOI] [PubMed] [Google Scholar]
  5. Chen M. F., Hwang T. L., Jeng L. B., Jan Y. Y., Wang C. S., Chou F. F. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg. 1989 Sep;124(9):1025–1028. doi: 10.1001/archsurg.1989.01410090031006. [DOI] [PubMed] [Google Scholar]
  6. Di Carlo V., Ferrari G., Castoldi R., Nadalin S., Marenghi C., Molteni B., Taccagni G., Castrucci M. Surgical treatment and prognostic variables of hepatocellular carcinoma in 122 cirrhotics. Hepatogastroenterology. 1995 Jul;42(3):222–229. [PubMed] [Google Scholar]
  7. Hsu H. C., Chiou T. J., Chen J. Y., Lee C. S., Lee P. H., Peng S. Y. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology. 1991 May;13(5):923–928. [PubMed] [Google Scholar]
  8. Ikeda K., Saitoh S., Tsubota A., Arase Y., Chayama K., Kumada H., Watanabe G., Tsurumaru M. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer. 1993 Jan 1;71(1):19–25. doi: 10.1002/1097-0142(19930101)71:1<19::aid-cncr2820710105>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  9. Iwatsuki S., Starzl T. E., Sheahan D. G., Yokoyama I., Demetris A. J., Todo S., Tzakis A. G., Van Thiel D. H., Carr B., Selby R. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991 Sep;214(3):221–229. doi: 10.1097/00000658-199109000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Izumi R., Shimizu K., Ii T., Yagi M., Matsui O., Nonomura A., Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994 Mar;106(3):720–727. doi: 10.1016/0016-5085(94)90707-2. [DOI] [PubMed] [Google Scholar]
  11. Kar S., Carr B. I. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology. 1995 Feb;21(2):403–407. [PubMed] [Google Scholar]
  12. MacColl C., MacCannell K. L., Baylis B., Lee S. S. Treatment of acute colonic pseudoobstruction (Ogilvie's syndrome) with cisapride. Gastroenterology. 1990 Mar;98(3):773–776. doi: 10.1016/0016-5085(90)90301-g. [DOI] [PubMed] [Google Scholar]
  13. MacIntosh E. L., Minuk G. Y. Hepatic resection in patients with cirrhosis and hepatocellular carcinoma. Surg Gynecol Obstet. 1992 Mar;174(3):245–254. [PubMed] [Google Scholar]
  14. Masutani S., Sasaki Y., Imaoka S., Iwamoto S., Ohashi I., Kameyama M., Kabuto T., Ishikawa O., Furukawa H., Koyama H. The prognostic significance of surgical margin in liver resection of patients with hepatocellular carcinoma. Arch Surg. 1994 Oct;129(10):1025–1030. doi: 10.1001/archsurg.1994.01420340039007. [DOI] [PubMed] [Google Scholar]
  15. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693–699. doi: 10.1056/NEJM199603143341104. [DOI] [PubMed] [Google Scholar]
  16. McPeake J. R., O'Grady J. G., Zaman S., Portmann B., Wight D. G., Tan K. C., Calne R. Y., Williams R. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol. 1993 Jun;18(2):226–234. doi: 10.1016/s0168-8278(05)80250-8. [DOI] [PubMed] [Google Scholar]
  17. Michel J., Suc B., Fourtanier G., Durand D., Rumeau J. L., Rostaing L., Lloveras J. J. Recurrence of hepatocellular carcinoma in cirrhotic patients after liver resection or transplantation. Transplant Proc. 1995 Apr;27(2):1798–1800. [PubMed] [Google Scholar]
  18. Miller W. J., Federle M. P., Campbell W. L. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients. AJR Am J Roentgenol. 1991 Aug;157(2):303–306. doi: 10.2214/ajr.157.2.1649550. [DOI] [PubMed] [Google Scholar]
  19. Nagasue N., Uchida M., Makino Y., Takemoto Y., Yamanoi A., Hayashi T., Chang Y. C., Kohno H., Nakamura T., Yukaya H. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993 Aug;105(2):488–494. doi: 10.1016/0016-5085(93)90724-q. [DOI] [PubMed] [Google Scholar]
  20. Otto G., Heuschen U. A., Hofmann W. J., Herfarth C. Primary hepatic malignancies: resection or liver transplantation? Eur J Surg Oncol. 1990 Aug;16(4):346–351. [PubMed] [Google Scholar]
  21. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991 Oct;110(4):726–735. [PubMed] [Google Scholar]
  22. Ringe B., Pichlmayr R., Wittekind C., Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991 Mar-Apr;15(2):270–285. doi: 10.1007/BF01659064. [DOI] [PubMed] [Google Scholar]
  23. Rizzi P. M., Kane P. A., Ryder S. D., Ramage J. K., Gane E., Tan K. C., Portmann B., Karani J., Williams R. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology. 1994 Nov;107(5):1425–1429. doi: 10.1016/0016-5085(94)90545-2. [DOI] [PubMed] [Google Scholar]
  24. Romani F., Belli L. S., Rondinara G. F., DeCarlis L., Rimoldi P., Riolo F., Bellati G., Ideo G., Belli L. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver. J Am Coll Surg. 1994 Apr;178(4):379–384. [PubMed] [Google Scholar]
  25. Rustgi V. K. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am. 1987 Dec;16(4):545–551. [PubMed] [Google Scholar]
  26. Sasaki Y., Imaoka S., Masutani S., Ohashi I., Ishikawa O., Koyama H., Iwanaga T. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery. 1992 Sep;112(3):515–521. [PubMed] [Google Scholar]
  27. Schwartz M. E., Sung M., Mor E., Fisher A., Popescu I., Fiel I., Sheiner P., Emre S., Guy S., Miller C. M. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg. 1995 May;180(5):596–603. [PubMed] [Google Scholar]
  28. Scudamore C. H., Ragaz J., Kluftinger A. M., Owen D. A. Hepatocellular carcinoma. A comparison of Oriental and Caucasian patients. Am J Surg. 1988 May;155(5):659–662. doi: 10.1016/s0002-9610(88)80138-7. [DOI] [PubMed] [Google Scholar]
  29. Selby R., Kadry Z., Carr B., Tzakis A., Madariaga J. R., Iwatsuki S. Liver transplantation for hepatocellular carcinoma. World J Surg. 1995 Jan-Feb;19(1):53–58. doi: 10.1007/BF00316980. [DOI] [PubMed] [Google Scholar]
  30. Tan C. K., Gores G. J., Steers J. L., Porayko M. K., Hay J. E., Rakela J., Wiesner R. H., Krom R. A. Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc. 1994 Jun;69(6):509–514. doi: 10.1016/s0025-6196(12)62240-x. [DOI] [PubMed] [Google Scholar]
  31. Wands J. R., Blum H. E. Primary hepatocellular carcinoma. N Engl J Med. 1991 Sep 5;325(10):729–731. doi: 10.1056/NEJM199109053251010. [DOI] [PubMed] [Google Scholar]
  32. Yokoyama I., Carr B., Saitsu H., Iwatsuki S., Starzl T. E. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer. 1991 Nov 15;68(10):2095–2100. doi: 10.1002/1097-0142(19911115)68:10<2095::aid-cncr2820681002>3.0.co;2-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES